Erratum to: Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade (Pflugers Archiv - European Journal of Physiology (2012) 463, (537-548) DOI: 10.1007/s00424-011-1061-z);Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade

Pflugers Archiv European Journal of Physiology

Volumn 463, Issue 4, 2012, Pages 537-548

  Marshall, Gillian E ^a   Russell, Julie A ^a   Tellez, James O ^b   Jhund, Pardeep S ^a   Currie, Susan ^c   Dempster, John ^c   Boyett, Mark R ^b   Kane, Kathleen A ^c   Rankin, Andrew C ^a   Workman, Antony J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Action potential; Atrial myocyte; Human; Ion channel; Ion current; adrenoceptor

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT I K1; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT I KSUS; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT I TO; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; ION CHANNEL; ISOPRENALINE; MESSENGER RNA; NICORANDIL; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ADULT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG ACTIVITY; ELECTROPHORESIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART REPOLARIZATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NUCLEOTIDE SEQUENCE; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WESTERN BLOTTING;

EID: 84860633289     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-014-1505-3     Document Type: Erratum

References (37)

1. V4 channels. Channels 4:168-178
2. Bru-Mercier G, Deroubaix E, Rousseau D, Coulombe A, Renaud J-F (2002) Depressed transient outward potassium current density in catecholamine-depleted rat ventricular myocytes. Am J Physiol 282:H1237-H1247 (Pubitemid 34654874)
3. Camm AJ, Kirchof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Goronek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH (2010) Guidelines for the management of atrial fibrillation. The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:2369-2429
4. Cao F, Huang CX, Wang T, Li X, Jiang H, Bao MW (2006) Effects of carvedilol on rabbit atrial cell electrophysiology. Heart Rhythm 3(Suppl 1):S178, Abstract
5. 2+current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110:2651-2657
6. Courtemanche M, Ramirez RJ, Nattel S (1998) Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol 275:H301-H321
7. Courtemanche M, Ramirez RJ, Nattel S (1999) Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovasc Res 42:477-489 (Pubitemid 29243173)
8. Dawodu AA, Monti F, Iwashiro K, Schiariti M, Chiavarelli R, Puddu PE (1996) The shape of human atrial action potential accounts for different frequency-related changes in vitro. Int J Cardiol 54:237-249 (Pubitemid 26226637)
9. Dobrev D, Ravens U (2003) Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 98:137-148 (Pubitemid 36740668)
10. Escande D, Coulombe A, Faivre JF, Coraboeuf E (1987) Two types of transient outward currents in adult human atrial cells. Am J Physiol 252:H142-H148
11. Fermini B, Wang Z, Duan D, Nattel S (1992) Differences in rate dependence of transient outward current in rabbit and human atrium. Am J Physiol 263:H1747-H1754 (Pubitemid 23030727)
12. + currents to repolarization assessed using mathematical models of human ventricular myocytes. Philo Trans R Soc A 364:1207-1222
13. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S (2005) Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112:471-481 (Pubitemid 41060786)
14. to1 in shaping action potential morphology and duration. Circ Res 87:1026-1033
15. Ca, L in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 375:383-392
16. 2.1b is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system. Circulation 106:1493-1499
17. Kong W, Po S, Yamagishi T, Ashen MD, Stetten G, Tomaselli GF (1998) Isolation and characterization of the human gene encoding Ito: further diversity by alternative mRNA splicing. Am J Physiol 275:H1963-H1970
18. Koumi S, Backer CL, Arentzen CE, Sato R (1995) β-adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to β- adrenergic stimulation in failing human hearts. J Clin Invest 96:2870-2881
19. + channel with a novel structure. EMBO J 15:1004-1011
20. + current in human atrial myocytes. Circ Res 78:903-915
21. + currents in rat epicardial myocytes. Am J Physiol 274:H915-H922
22. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C (2004) Expert consensus document on β-adrenergic receptor blockers. The task force on beta-blockers of the European Society of Cardiology. Eur Heart J 25:1341-1362
23. Maguy A, Hebert TE, Nattel S (2006) Involvement of lipid rafts and caveolae in cardiac ion channel function. Cardiovasc Res 69:798-807 (Pubitemid 43227978)
24. Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425-456 (Pubitemid 47084677)
25. + channel diversity in the mammalian myocardium. J Physiol 525:285-298
26. Nerbonne JM, Kass RS (2005) Molecular physiology of cardiac repolarization. Physiol Rev 85:1205-1253 (Pubitemid 41362269)
27. to) expression and regulation. J Mol Cell Cardiol 48:12-25
28. Pandit SV, Berenfeld O, Anumonwo JMB, Zaritski RM, Kneller J, Nattel S, Jalife J (2005) Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 88:3806-3821 (Pubitemid 40991096)
29. Raine AEG, Vaughan Williams EM (1981) Adaptation to prolonged β-blockade of rabbit atrial, Purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation. Circ Res 48:804-812 (Pubitemid 11126068)
30. Redpath CJ, Rankin AC, Kane KA, Workman AJ (2006) Antiadrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol 40:717-724
31. 2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation. J Mol Cell Cardiol 35:437-443
32. Workman AJ (2010) Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol 381:235-249
33. Workman AJ, Kane KA, Rankin AC (2001) The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 52:226-235 (Pubitemid 33000399)
34. Workman AJ, Kane KA, Rankin AC (2008) Cellular bases for human atrial fibrillation. Heart Rhythm 5:S1-S6
35. Workman AJ, Kane KA, Russell JA, Norrie J, Rankin AC (2003) Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res 58:518-525 (Pubitemid 36694437)
36. Workman AJ, Smith GL, Rankin AC (2011) Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther 131:221-241
37. Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q (2006) Subtype-specific α1- and β-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27:330-337